{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## **1. Regroupement en sous-corpus**\n",
    "Plutôt que de récupérer un tag qui aurait été assigné manuellement pour chaque lien, on va le créer en déconstruisant les URLs et en créant des sous-dossiers correspondant à différents sous-niveaux dans l'arborescence du site.  \n",
    "\n",
    "À décider : jusqu'à quel niveau on regroupe (ça peut être un peu du cas par cas selon l'organisation du site)\n",
    "\n",
    "Créer des sous-dossiers à l'intérieur"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Address</th>\n",
       "      <th>Title</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>https:////www.inesss.qc.ca//</td>\n",
       "      <td>INESSS: WWW</td>\n",
       "      <td>INESSS - Le savoir prend forme Suivi de l’évol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>https:////www.inesss.qc.ca//accueil.html</td>\n",
       "      <td>INESSS: Accueil</td>\n",
       "      <td>INESSS - Le savoir prend forme Suivi de l’évol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>https:////www.inesss.qc.ca//index.html</td>\n",
       "      <td>INESSS: WWW</td>\n",
       "      <td>INESSS - Le savoir prend forme Suivi de l’évol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>https:////www.inesss.qc.ca//plan-du-site.html</td>\n",
       "      <td>INESSS: Plan du site</td>\n",
       "      <td>COVID-19 Risques d’hospitalisation et projecti...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>https:////www.inesss.qc.ca//nous-joindre.html</td>\n",
       "      <td>INESSS: Nous joindre</td>\n",
       "      <td>Heures d’ouverture de l’INESSS Du lundi au ven...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1221</th>\n",
       "      <td>https:////www.inesss.qc.ca//thematiques//medic...</td>\n",
       "      <td>Janvier 1990</td>\n",
       "      <td>Rapid Response Gluco-MD Blood Glucose Test Str...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1222</th>\n",
       "      <td>https:////www.inesss.qc.ca//thematiques//medic...</td>\n",
       "      <td>Janvier 1990</td>\n",
       "      <td>Tykess (mesure de la glycémie) Dénomination co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1223</th>\n",
       "      <td>https:////www.inesss.qc.ca//thematiques//medic...</td>\n",
       "      <td>Janvier 1990</td>\n",
       "      <td>MediSure Empower (mesure de la glycémie) Dénom...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1224</th>\n",
       "      <td>https:////www.inesss.qc.ca//thematiques//medic...</td>\n",
       "      <td>Novembre 2018</td>\n",
       "      <td>Actikerall (kératose actinique) Dénomination c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1225</th>\n",
       "      <td>https:////www.inesss.qc.ca//thematiques//medic...</td>\n",
       "      <td>Février 2017</td>\n",
       "      <td>Actikerall Dénomination commune // Sujet : flu...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1226 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                Address                 Title  \\\n",
       "0                          https:////www.inesss.qc.ca//           INESSS: WWW   \n",
       "1              https:////www.inesss.qc.ca//accueil.html       INESSS: Accueil   \n",
       "2                https:////www.inesss.qc.ca//index.html           INESSS: WWW   \n",
       "3         https:////www.inesss.qc.ca//plan-du-site.html  INESSS: Plan du site   \n",
       "4         https:////www.inesss.qc.ca//nous-joindre.html  INESSS: Nous joindre   \n",
       "...                                                 ...                   ...   \n",
       "1221  https:////www.inesss.qc.ca//thematiques//medic...          Janvier 1990   \n",
       "1222  https:////www.inesss.qc.ca//thematiques//medic...          Janvier 1990   \n",
       "1223  https:////www.inesss.qc.ca//thematiques//medic...          Janvier 1990   \n",
       "1224  https:////www.inesss.qc.ca//thematiques//medic...         Novembre 2018   \n",
       "1225  https:////www.inesss.qc.ca//thematiques//medic...          Février 2017   \n",
       "\n",
       "                                                   text  \n",
       "0     INESSS - Le savoir prend forme Suivi de l’évol...  \n",
       "1     INESSS - Le savoir prend forme Suivi de l’évol...  \n",
       "2     INESSS - Le savoir prend forme Suivi de l’évol...  \n",
       "3     COVID-19 Risques d’hospitalisation et projecti...  \n",
       "4     Heures d’ouverture de l’INESSS Du lundi au ven...  \n",
       "...                                                 ...  \n",
       "1221  Rapid Response Gluco-MD Blood Glucose Test Str...  \n",
       "1222  Tykess (mesure de la glycémie) Dénomination co...  \n",
       "1223  MediSure Empower (mesure de la glycémie) Dénom...  \n",
       "1224  Actikerall (kératose actinique) Dénomination c...  \n",
       "1225  Actikerall Dénomination commune // Sujet : flu...  \n",
       "\n",
       "[1226 rows x 3 columns]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "path = '../03-corpus/2-data/1-fr/'\n",
    "acteur = \"inesss\"\n",
    "\n",
    "from pandas import *\n",
    "\n",
    "# encoding= 'ISO-8859-1' \"utf-8\"\n",
    "with open(path + acteur  + '.csv', encoding='utf-8') as f:\n",
    "    csv = read_csv(f, sep=',')[[\"Address\", 'Title', \"text\"]]\n",
    "\n",
    "csv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['https://www.inesss.qc.ca/',\n",
       " 'https://www.inesss.qc.ca/accueil.html',\n",
       " 'https://www.inesss.qc.ca/index.html',\n",
       " 'https://www.inesss.qc.ca/plan-du-site.html',\n",
       " 'https://www.inesss.qc.ca/salle-de-presse.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/outils-cliniques/outils-par-types/algorithmes.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/outils-cliniques/outils-par-types/guides-dusage-optimal.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/outils-cliniques.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/protocoles-medicaux-nationaux-et-ordonnances-associees.html',\n",
       " 'https://www.inesss.qc.ca/covid-19.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/risques-dhospitalisation-et-projections-des-besoins-hospitaliers.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/affections-post-covid-19-covid-19-longue.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/alternatives-de-traitements-en-contexte-de-pandemie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/autres-traitements.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/etudes-cliniques-en-cours-prophylaxie-et-traitement.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/ordonnances-collectives.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/regard-sur-la-pandemie-covid-19-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/presentations-cliniques.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/investigation-procedures-diagnostiques.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/retablissement-et-reprise-des-activites.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/methode-de-reponse-rapide-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/contributions-des-uetmis.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/sites-dinteret.html',\n",
       " 'https://www.inesss.qc.ca/metho-et-veille/demarche.html',\n",
       " 'https://www.inesss.qc.ca/thematiques.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-usage-optimal.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/biologie-medicale-et-genomique/biologie-medicale-et-genomique.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cancerologie.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cardiologie-et-maladies-neurovasculaires.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/depistage-et-pratiques-cliniques-preventives.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/imagerie-medicale.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/innovations-technologiques-et-dispositifs-medicaux.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/modes-dintervention-en-sante.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/produits-du-systeme-du-sang/produits-du-systeme-du-sang.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/soins-critiques.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/therapies-cellulaires.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/deficiences-physiques-intellectuelles-et-tsa.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/dependance-et-itinerance.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/jeunes-et-familles.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/personnes-agees.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/sante-mentale.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/services-sociaux-generaux.html',\n",
       " 'https://www.inesss.qc.ca/publications/algorithmes.html',\n",
       " 'https://www.inesss.qc.ca/publications/commander-une-publication.html',\n",
       " 'https://www.inesss.qc.ca/publications/guides-dusage-optimal.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours.html',\n",
       " 'https://www.inesss.qc.ca/projets/indicateurs-de-qualite-maladies-chroniques/indicateurs-de-qualite-prise-en-charge-des-maladies-chroniques.html',\n",
       " 'https://www.inesss.qc.ca/formations-et-outils-cliniques.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/webinaires-et-capsules-videos/formations.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/approche-methodologique.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/suivi-de-levolution-de-lepidemie-de-covid-19-portrait-et-projections-des-hospitalisations-mise-a-jour-du-20-juillet-2022.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/toutes-les-nouveautes.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/suivi-de-levolution-de-lepidemie-de-covid-19-portrait-et-projections-des-hospitalisations-mise-a-jour-du-13-juillet-2022.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/suivi-de-levolution-de-lepidemie-de-covid-19-portrait-et-projections-des-hospitalisations-mise-a-jour-du-6-juillet-2022.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/les-trajectoires-de-services-et-les-services-pour-les-enfants-a-risque-de-negligence-ou-en-situation-de-negligence-et-leur-famille.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panels-des-maladies-cardiovasculaires-hereditaires-par-sequencage-de-nouvelle-generation-rapport-devaluation-sur-le-rapatriement-danalyses-realisees-hors-quebec.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-des-microchirurgies-pour-la-prevention-et-le-traitement-du-lymphoedeme-lie-au-cancer.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/densite-mammographique-et-depistage-en-cancer-du-sein.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/algorithme-de-gestion-du-risque-de-complications-neurologiques-graves-suite-a-un-tcc-leger.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/evaluation-des-interventions-de-readaptation-pour-les-enfants-0-12-ans-presentant-un-trouble-du-spectre-de-lautisme.html',\n",
       " 'https://www.inesss.qc.ca/naviguer-selon-le-profil/professionnels.html',\n",
       " 'https://www.inesss.qc.ca/naviguer-selon-le-profil/patients.html',\n",
       " 'https://www.inesss.qc.ca/naviguer-selon-le-profil/collaborateurs-institutionnels.html',\n",
       " 'https://www.inesss.qc.ca/acces-a-linformation.html',\n",
       " 'https://www.inesss.qc.ca/accessibilite.html',\n",
       " 'https://www.inesss.qc.ca/declaration-de-services-aux-citoyens.html',\n",
       " 'https://www.inesss.qc.ca/developpement-durable.html',\n",
       " 'https://www.inesss.qc.ca/realisation.html',\n",
       " 'https://www.inesss.qc.ca/diffusion-de-linformation.html',\n",
       " 'https://www.inesss.qc.ca/typo3conf/ext/inesss/Resources/Public/Images/inesss-shape--grey.svg',\n",
       " 'https://www.inesss.qc.ca/typo3conf/ext/inesss/Resources/Public/Images/inesss-shape--white.svg',\n",
       " 'https://www.inesss.qc.ca/covid-19/methode-de-reponse-rapide-covid-19/elaboration-et-mise-en-oeuvre-de-la-methode-de-reponse-rapide-dans-le-contexte-de-la-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/contributions-des-uetmis/soins-intensifs-ventilation-assistee-echangeur-de-chaleur.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/sites-dinteret/visitez-linspq.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/sites-dinteret/visitez-le-msss.html',\n",
       " 'https://www.inesss.qc.ca/metho-et-veille/demarche/nos-principes-et-fondements-ethiques.html',\n",
       " 'https://www.inesss.qc.ca/metho-et-veille/demarche/nos-politiques-lignes-directrices-et-processus.html',\n",
       " 'https://www.inesss.qc.ca/metho-et-veille/demarche/nos-publications-de-veille-strategique.html',\n",
       " 'https://www.inesss.qc.ca/metho-et-veille/demarche/nos-publications-de-veille-strategique/evolution-des-modalites-dacces-de-remboursement-et-de-soutien-a-limplantation-des-innovations.html',\n",
       " 'https://www.inesss.qc.ca/metho-et-veille/demarche/nos-publications-de-veille-strategique/tendances-des-depenses-et-des-developpements-technologiques-en-medicaments.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/avis-au-ministre.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/avis-sur-les-prix.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/approche-modalites-et-processus-devaluation.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/approche-modalites-et-processus-devaluation/modalites-devaluation-des-medicaments-aux-fins-dinscription.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/approche-modalites-et-processus-devaluation/medicaments-en-attente-dun-avis-de-conformite.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/approche-modalites-et-processus-devaluation/medicaments-dexception.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/approche-modalites-et-processus-devaluation/evaluation-des-medicaments-biosimilaires.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/approche-modalites-et-processus-devaluation/evaluation-dune-demande-dexemption-de-la-methode-du-prix-le-plus-bas-ppb.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/rendez-vous-des-fabricants.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/rendez-vous-des-fabricants/rencontre-presoumission-avec-les-fabricants.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/rendez-vous-des-fabricants/preavis-obligatoire-demande-aux-fabricants.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/rendez-vous-des-fabricants/demande-dinscription.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/rendez-vous-des-fabricants/adhesion-au-depot-electronique-dune-demande-dinscription-fiche-6.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/rendez-vous-des-fabricants/depot-electronique-dune-demande-dinscription-fiche-6.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/rendez-vous-des-fabricants/depot-electronique-temporaire-pour-les-demandes-dinscription-autres-fiches.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/rendez-vous-des-fabricants/rencontre-postsoumission-avec-les-fabricants.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/rendez-vous-des-fabricants/avis-aux-fabricants.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/rendez-vous-des-fabricants/echeancier-des-mises-a-jour-en-2021.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/rendez-vous-des-fabricants/echeancier-des-mises-a-jour-en-2022.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/rendez-vous-des-fabricants/tarification.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/foire-aux-questions-sur-les-medicaments.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/foire-aux-questions-sur-les-medicaments/hepatite-c.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/foire-aux-questions-sur-les-medicaments/maladie-pulmonaire-obstructive-chronique.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/foire-aux-questions-sur-les-medicaments/medicaments-biosimilaires.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/foire-aux-questions-sur-les-medicaments/medicaments-dexception-oncologie.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/foire-aux-questions-sur-les-medicaments/medicaments-generiques.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/foire-aux-questions-sur-les-medicaments/produits-de-sante-naturels.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/foire-aux-questions-sur-les-medicaments/virus-de-limmunodeficience-humaine.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/tutoriels.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/gabarits.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/protocoles-medicaux-nationaux-et-ordonnances-associees/aide-medicale-a-mourir.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/anticoagulotherapie.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/antidiabetique.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/antidiabetique/faq-antidiabetique-formulations-combinees.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/candidose-buccale-chez-ladulte.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/chlamydia-et-gonorrhoeae.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/protocoles-medicaux-nationaux-et-ordonnances-associees/davc.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/eampoc.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/ecoulement-uretral.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/elimination-fecale.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/hydroxychloroquine-et-chloroquine.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/hypertension-arterielle.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/hypolipemiants.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/protocoles-medicaux-nationaux-et-ordonnances-associees/infections-urinaires.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/inhibiteurs-de-la-pompe-a-protons-ipp.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/maladie-de-lyme-ppe.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/protocoles-medicaux-nationaux-et-ordonnances-associees/mucosite-oropharyngee.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/naloxone.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/pertes-vaginales-inhabituelles.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/premarin.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/protocoles-medicaux-nationaux-et-ordonnances-associees/retention-urinaire-aiguee.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/protocoles-medicaux-nationaux-et-ordonnances-associees/sedation-palliative-continue.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/soins-palliatifs-detresse.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/soins-palliatifs-fievre.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/soins-palliatifs-nausees.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/protocoles-medicaux-nationaux-et-ordonnances-associees/traitement-au-fer-intraveineux-chez-ladulte.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/trouble-depressif-caracterise-majeur.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/protocoles-medicaux-nationaux-et-ordonnances-associees/trouble-lie-a-lusage-dalcool.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/troubles-neurocognitifs.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/document-complementaire.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/document-complementaire/addenda-medecins-signataires.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/plan-de-travail.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/foire-aux-questions.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/foire-aux-questions/itss.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/foire-aux-questions/ordonnance-collective.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/foire-aux-questions/ordonnance-individuelle.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/foire-aux-questions/professionnels-impliques.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/foire-aux-questions/protocole-medical.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/foire-aux-questions/problemes-techniques.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/protocoles-medicaux-nationaux-et-ordonnances-associees/foire-aux-questions/autres-questions.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/biologie-medicale-et-genomique/processus-et-criteres-devaluation.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/biologie-medicale-et-genomique/processus-synchronise-devaluation-des-tests-compagnons.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/biologie-medicale-et-genomique/soutien-au-diagnostic-moleculaire.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/biologie-medicale-et-genomique/avis-au-ministre.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/produits-du-systeme-du-sang/produits-du-systeme-du-sang/avis-au-ministre.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/produits-du-systeme-du-sang/processus-devaluation.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/produits-du-systeme-du-sang/processus-devaluation/preavis-obligatoire-demande-aux-fabricants.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/produits-du-systeme-du-sang/processus-devaluation/pss-en-attente-dun-avis-de-conformite.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/produits-du-systeme-du-sang/information-pour-les-fabricants.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/produits-du-systeme-du-sang/information-pour-les-fabricants/avis-aux-fabricants.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/produits-du-systeme-du-sang/information-pour-les-fabricants/faire-une-demande-dajout.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/produits-du-systeme-du-sang/information-pour-les-fabricants/rencontre-presoumission-avec-les-fabricants.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/produits-du-systeme-du-sang/information-pour-les-fabricants/rencontre-postsoumission-avec-les-fabricants.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/produits-du-systeme-du-sang/information-pour-les-fabricants/tarification.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie/continuum-de-services-en-traumatologie-cst.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie/continuum-de-services-en-traumatologie-cst/historique.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie/continuum-de-services-en-traumatologie-cst/structure.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie/continuum-de-services-en-traumatologie-cst/partenaires-et-mandats.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie/continuum-de-services-en-traumatologie-cst/recherche.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie/continuum-de-services-en-traumatologie-cst/registre-des-traumatismes.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie/continuum-de-services-en-traumatologie-cst/evaluation-du-reseau.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie/documentation.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie/documentation/publications-diverses.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie/documentation/outils.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie/documentation/evenements-congres-et-colloques-en-traumatologie.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie/documentation/liens-interessants.html',\n",
       " 'https://www.inesss.qc.ca/projets/maladies-chroniques-indicateurs/prise-en-charge-254/publications.html',\n",
       " 'https://www.inesss.qc.ca/projets/maladies-chroniques-indicateurs/prise-en-charge-254/base-de-donnees.html',\n",
       " 'https://www.inesss.qc.ca/projets/maladies-chroniques-indicateurs/prise-en-charge-254/base-de-donnees/introduction.html',\n",
       " 'https://www.inesss.qc.ca/projets/maladies-chroniques-indicateurs/prise-en-charge-254/base-de-donnees/mode-demploi.html',\n",
       " 'https://www.inesss.qc.ca/projets/maladies-chroniques-indicateurs/prise-en-charge-254/base-de-donnees/sondage.html',\n",
       " 'https://www.inesss.qc.ca/projets/maladies-chroniques-indicateurs/prise-en-charge-254/base-de-donnees/references.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/outils-cliniques/outils-par-thematiques.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/outils-cliniques/outils-par-types.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/outils-cliniques/outils-par-types/resumes-fiches-syntheses-depliants-diffusion.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/outils-cliniques/outils-par-types/aide-a-la-decision-dialogue-patient-aide-memoire-appropriation.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/outils-cliniques/soutenir-la-prise-de-decision-partagee.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/webinaires-et-capsules-videos/capsules-videos.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/algorithmes-dinvestigation-de-traitement-et-de-suivi-pour-le-cancer-du-colon.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/algorithmes-dinvestigation-de-traitement-et-de-suivi-pour-le-lymphome-de-hodgkin.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-du-depistage-du-cancer-du-poumon-par-la-tomographie-axiale-a-faible-dose.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/algorithmes-dinvestigation-de-traitement-et-de-suivi-pour-le-cancer-de-la-prostate.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-du-dosage-de-lantigene-prostatique-specifique-aps-pour-le-depistage-du-cancer-de-la-prostate-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/algorithmes-dinvestigation-de-traitement-et-de-suivi-pour-le-cancer-du-rectum.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/algorithmes-dinvestigation-de-traitement-et-de-suivi-du-cancer-du-sein.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/principales-indications-de-lirm-mammaire-dans-le-contexte-de-linvestigation-et-de-la-planification-du-traitement-du-cancer-du-sein.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/avis-utilisation-dendopredictmc-et-prosignamc-dans-les-cas-de-cancer-du-sein-invasif-precoce.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/tomosynthese-et-cancer-du-sein-evaluation-diagnostique-et-autres-utilisations.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/statines-hypolipemiants-et-diminution-du-risque-cardiovasculaire.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-et-gestion-du-risque-de-complications-neurologiques-graves-a-la-suite-dun-traumatisme-craniocerebral-leger.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications.html?tx_solr%5Bpage%5D=2',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications.html?tx_solr%5Bpage%5D=3',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications.html?tx_solr%5Bpage%5D=4',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications.html?tx_solr%5Bpage%5D=5',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications.html?tx_solr%5Bpage%5D=6',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications.html?tx_solr%5Bpage%5D=7',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications.html?tx_solr%5Bpage%5D=8',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications.html?tx_solr%5Bpage%5D=9',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications.html?tx_solr%5Bpage%5D=10',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/risques-dhospitalisation-et-de-deces-en-lien-avec-la-covid-19-chez-les-personnes-avec-une-deficience-intellectuelle-di-ou-un-trouble-du-spectre-de-lautisme-tsa.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/risques-dhospitalisation-et-de-deces-en-lien-avec-la-covid-19-chez-les-usagers-des-services-de-readaptation-presentant-une-deficience-physique.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/efficacite-des-interventions-psychosociales-pour-prevenir-et-traiter-les-symptomes-et-troubles-mentaux-courants.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-de-fibrygamc-concentre-de-fibrinogene-humain-deficit-acquis-en-fibrinogene.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/profilage-moleculaire-des-tumeurs-solides-adultes-focus-panelmc-illuminamc-analyse-de-52-biomarqueurs-somatiques.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/le-transport-medical-heliporte-tmh-analyse-des-besoins-et-identification-des-clienteles.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/la-transplantation-dorganes-solides-volet-1-portrait-de-la-transplantation-cardiaque-et-pulmonaire-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/guide-dusage-optimal-pour-le-traitement-pharmacologique-de-la-maladie-dalzheimer-et-de-la-demence-mixte.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/reperage-et-processus-menant-au-diagnostic-de-la-maladie-dalzheimer-et-dautres-troubles-neurocognitifs.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/avis-sur-la-standardisation-des-pratiques-relatives-aux-allergies-aux-beta-lactamines-modifications-apportees-au-rapport-du-20-fevrier-2017.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/anticoagulants-oraux-directs-et-warfarine-dans-la-fibrillation-auriculaire-et-la-thromboembolie-veineuse.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/guides-dusage-optimal-pour-la-cellulite-infectieuse.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/guide-dusage-optimal-pour-le-traitement-de-la-diarrhee-ou-de-la-colite-associee-a-clostridium-difficile.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-des-antiviraux-pour-le-traitement-et-la-prophylaxie-de-linfluenza-chez-lenfant-et-ladulte-dans-le-contexte-de-la-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/transplantation-des-ilots-de-langerhans-chez-les-personnes-atteintes-dun-diabete-de-type-1-instable.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/autosurveillance-glycemique-chez-les-adultes-atteints-de-diabete-de-type-2-non-traites-par-linsuline.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/prevention-devenements-cardiovasculaires-et-innocuite-des-inhibiteurs-du-sglt2-comparativement-aux-inhibiteurs-de-la-dpp-4-en-contexte-reel-chez-les-personnes-atteintes-de-diabete-de-type-2.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-des-pompes-intrathecales-dans-le-traitement-de-la-douleur-chronique-non-cancereuse.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/guide-dusage-optimal-des-immunoglobulines-en-neurologie.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/guide-dusage-optimal-des-immunoglobulines-en-hematologie.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-optimal-des-immunoglobulines-en-immunologie-clinique.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-optimal-des-immunoglobulines-en-rhumatologie.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-optimal-des-immunoglobulines-en-dermatologie.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-optimal-des-immunoglobulines-en-infectiologie.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-optimal-des-immunoglobulines-en-transplantation-dorganes-solides.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/guide-dusage-optimal-des-infections-urinaires-chez-ladulte.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/les-niveaux-de-soins.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/traitement-des-plaies-complexes-therapie-par-pression-negative-tpn.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?DemandePluginController%5BGENERIQUES_champDeTri%5D=nom_commercial&DemandePluginController%5BGENERIQUES_nom_commercial_triAscDesc%5D=ASC&DemandePluginController%5Bonglet%5D=0&cHash=a69781e1f45a15846b5f0c1fcbfd6d7c',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?DemandePluginController%5BGENERIQUES_champDeTri%5D=denomination_commune&DemandePluginController%5BGENERIQUES_denomination_commune_triAscDesc%5D=ASC&DemandePluginController%5Bonglet%5D=0&cHash=ca2cc0af6904aac5ea9685c72a8f32cb',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?DemandePluginController%5BGENERIQUES_champDeTri%5D=nom_fabricant&DemandePluginController%5BGENERIQUES_nom_fabricant_triAscDesc%5D=ASC&DemandePluginController%5Bonglet%5D=0&cHash=f720986a84d0ba858e658e4894d5ac42',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/faire-un-commentaire-sur-un-medicament.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?DemandePluginController%5BENCOURSHORSLISTE_champDeTri%5D=nom_commercial&DemandePluginController%5BENCOURSHORSLISTE_nom_commercial_triAscDesc%5D=ASC&DemandePluginController%5Bonglet%5D=1&cHash=58409815e3e7dec87b09cda8026f4248',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?DemandePluginController%5BENCOURSHORSLISTE_champDeTri%5D=denomination_commune&DemandePluginController%5BENCOURSHORSLISTE_denomination_commune_triAscDesc%5D=ASC&DemandePluginController%5Bonglet%5D=1&cHash=e01f9127787924c1970fb5a823dece43',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?DemandePluginController%5BENCOURSHORSLISTE_champDeTri%5D=nom_fabricant&DemandePluginController%5BENCOURSHORSLISTE_nom_fabricant_triAscDesc%5D=ASC&DemandePluginController%5Bonglet%5D=1&cHash=51295ab95565c4aa05ef9fbda5bc93c5',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?DemandePluginController%5BENCOURSHORSLISTE_champDeTri%5D=statut_demande&DemandePluginController%5BENCOURSHORSLISTE_statut_demande_triAscDesc%5D=ASC&DemandePluginController%5Bonglet%5D=1&cHash=f3a63a32febda37276d62328272ff46d',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?DemandePluginController%5BAUTRESEVALUATIONS_champDeTri%5D=nom_commercial&DemandePluginController%5BAUTRESEVALUATIONS_nom_commercial_triAscDesc%5D=ASC&DemandePluginController%5Bonglet%5D=2&cHash=5cc1c75640190df8fce2f0451c0551d1',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?DemandePluginController%5BAUTRESEVALUATIONS_champDeTri%5D=denomination_commune&DemandePluginController%5BAUTRESEVALUATIONS_denomination_commune_triAscDesc%5D=ASC&DemandePluginController%5Bonglet%5D=2&cHash=da7027fecbc6eb0281073ed8cdfa4253',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?tx_solr%5Bpage%5D=2',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?tx_solr%5Bpage%5D=3',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?tx_solr%5Bpage%5D=4',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?tx_solr%5Bpage%5D=5',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?tx_solr%5Bpage%5D=6',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?tx_solr%5Bpage%5D=7',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?tx_solr%5Bpage%5D=8',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?tx_solr%5Bpage%5D=9',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?tx_solr%5Bpage%5D=10',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/kyprolis-myelome-multiple-6398.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/risques-dhospitalisation-et-de-deces-en-lien-avec-la-covid-19-chez-les-personnes-avec-une-deficience-intellectuelle-di-ou-un-trouble-du-spectre-de-lautisme-tsa.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/risques-dhospitalisation-et-de-deces-en-lien-avec-la-covid-19-chez-les-usagers-des-services-de-readaptation-presentant-une-deficience-physique.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/fluvoxamine.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/amantadine-rimantadine.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/anticoagulants-en-dose-therapeutique.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/anticorps-monoclonaux-neutralisant-le-sras-cov-2.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/biotherapies-ciblant-la-voie-de-linterleukine-1.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/biotherapies-dirigees-contre-linterleukine-6-ou-son-recepteur-mise-a-jour-mineure-26-01-2022.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/chloroquine/hydroxychloroquine-mise-a-jour-completee-15-06-2020.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/colchicine.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/corticosteroides.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/inhibiteurs-des-janus-kinases-jak-mise-a-jour-mineure-25-01-22.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/interferons.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/ivermectine.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/lopinavir-ritonavir-kaletra-mise-a-jour-09-07-2020.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/nirmatrelvir-/-ritonavir-paxlovid.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/oseltamivir.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/radiotherapie-a-faible-dose-pour-le-traitement-de-la-pneumonie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/remdesivir.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/therapie-passive-par-anticorps-plasma-convalescent.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/tixagevimab-/-cilgavimab-evusheld-en-prophylaxie-preexposition.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/vitamine-d.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/grossesse-allaitement.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/presentation-clinique-et-medicaments-a-visee-therapeutique-en-pediatrie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/acces-aux-produits-et-interventions-prometteuses-dans-le-contexte-de-pandemie-un-choix-rigoureux-et-eclaire.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/covid-19-et-les-fondements-ethiques-de-lidentification-des-populations-prioritaires-pour-lacces-aux-traitements-rares-en-contexte-de-pandemie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/les-fondements-ethiques-de-levaluation-de-lequilibre-benefices-risques-dun-traitement-prometteur-en-contexte-de-pandemie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/affections-post-covid-19-covid-19-longue/interventions-de-readaptation-physique-pour-les-personnes-presentant-des-affections-post-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/affections-post-covid-19-covid-19-longue/organisation-des-soins-et-des-services-pour-la-prevention-et-la-prise-en-charge-des-affections-post-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/affections-post-covid-19-covid-19-longue/outil-daide-a-la-prise-en-charge-affections-post-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/affections-post-covid-19-covid-19-longue/pratiques-visant-a-mesurer-ou-reduire-les-symptomes-psychologiques-des-personnes-qui-presentent-une-affection-post-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/presentations-cliniques/signes-et-symptomes-physiques-et-psychologiques-post-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/alternatives-de-traitements-en-contexte-de-pandemie/aide-medicale-a-mourir.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/alternatives-de-traitements-en-contexte-de-pandemie/impact-de-la-substitution-du-coumadin-sur-les-tests-de-laboratoire.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/alternatives-de-traitements-en-contexte-de-pandemie/penurie-de-sedatifs-analgesiques-et-bloqueurs-neuromusculaires-alternatives-et-principes-de-sedation-aux-soins-intensifs-et-au-bloc-operatoire.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/alternatives-de-traitements-en-contexte-de-pandemie/prise-en-charge-de-linfarctus-aigu-du-myocarde-avec-elevation-du-segment-st-iamest.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/alternatives-de-traitements-en-contexte-de-pandemie/reanimation-cardiorespiratoire-rcr-en-contexte-hors-hospitalier.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/alternatives-de-traitements-en-contexte-de-pandemie/reanimation-cardiorespiratoire-rcr-pour-la-population-pediatrique-en-milieu-communautaire.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/alternatives-de-traitements-en-contexte-de-pandemie/soins-palliatifs-en-contexte-de-penuries-pendant-la-pandemie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/adenopathies-associees-au-vaccin-contre-la-covid-19-et-conduite-clinique-en-imagerie-oncologique.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/considerations-generales-concernant-le-traitement-du-cancer.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/cancers-urologiques-1.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/initiation-ou-reprise-des-traitements-oncologiques-chez-les-patients-infectes-a-la-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/portrait-des-personnes-avec-antecedent-de-cancer-infectees-par-le-sras-cov-2-durant-les-deux-premieres-vagues-de-la-pandemie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/radiotherapie-adjuvante-pour-le-traitement-du-cancer-du-sein-de-stade-precoce-efficacite-et-innocuite-dune-irradiation-complete-du-sein-en-5-fractions-ultra-hypofractionnement.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/radiotherapie-neoadjuvante-a-dose-unique-pour-le-traitement-des-patientes-atteintes-dun-cancer-du-sein-dans-un-contexte-ou-la-chirurgie-ne-peut-etre-effectuee-dans-un-delai-raisonnable.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/strategies-de-priorisation-des-patients-en-attente-dune-coloscopie-apres-un-resultat-positif-au-test-immunochimique-de-recherche-de-sang-occulte-dans-les-selles-rsosi.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/traitement-des-patients-atteints-de-cancer-et-gueris-de-la-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/cancers-colorectaux.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/cancers-digestifs-hauts.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/cancers-gynecologiques.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/cancers-orl-/-tete-et-cou.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/cancerologie/cancers-urologiques.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/autres-traitements/anti-inflammatoires-non-steroidiens.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/autres-traitements/anti-inflammatoires-non-steroidiens-chez-la-clientele-pediatrique.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/autres-traitements/dextromethorphane.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/autres-traitements/ieca.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/autres-traitements/interruption-volontaire-de-grossesse.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/autres-traitements/pratique-de-la-teleconsultation-en-medecine-de-premiere-ligne-et-medecine-specialisee-principes-generaux.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/autres-traitements/protoxyde-dazote-pendant-laccouchement.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/autres-traitements/utilisation-des-antiviraux-pour-le-traitement-et-la-prophylaxie-de-linfluenza-chez-lenfant-et-ladulte-dans-le-contexte-de-la-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/biologie-medicale-et-genomique.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/produits-du-systeme-du-sang.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/modes-dintervention-en-sante.html?PublicationPluginController%5Bpointer%5D=1&cHash=ed6afa9107135a72717ded1e5563a279',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/modes-dintervention-en-sante.html?PublicationPluginController%5Bpointer%5D=2&cHash=ae1eb9f21c233efc9b8bf61226531ba1',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/modes-dintervention-en-sante.html?PublicationPluginController%5Bpointer%5D=3&cHash=46979981e83171f03bced93fdcc831e4',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/modes-dintervention-en-sante.html?PublicationPluginController%5Bpointer%5D=4&cHash=74ce83f4ba414a35b1a2dc494a7059dd',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/modes-dintervention-en-sante.html?PublicationPluginController%5Bpointer%5D=5&cHash=83144fe6e3302c43fd4a2821527e23b6',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/modes-dintervention-en-sante.html?PublicationPluginController%5Bpointer%5D=6&cHash=f2f15e9a2a8bf59232e961895e67b2d8',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/modes-dintervention-en-sante.html?PublicationPluginController%5Bpointer%5D=7&cHash=cf554b19d0b63603bf04015745c2afab',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/modes-dintervention-en-sante.html?PublicationPluginController%5Bpointer%5D=8&cHash=13c56c2ad73febbae3c8dea2edfa51e2',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/modes-dintervention-en-sante.html?PublicationPluginController%5Bpointer%5D=9&cHash=5357f6e8b4ccb9c80bd4c7dfebc4a046',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/modalites-et-trajectoire-diagnostiques-de-la-coqueluche.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/portrait-de-lutilisation-des-soins-et-des-services-de-soutien-a-domicile-par-les-personnes-en-fin-de-vie-au-quebec-2013-2018.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/modalites-de-consentement-et-options-de-disposition-des-embryons-conserves-a-la-suite-dun-processus-de-fecondation-in-vitro.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/imagerie-medicale.html?PublicationPluginController%5Bpointer%5D=1&cHash=25b50997d66e3e3459b68bfeea3d576c',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/imagerie-medicale.html?PublicationPluginController%5Bpointer%5D=2&cHash=3dc92eaeafcf12b50b88285366802ed6',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-optimal-de-lechographie-cardiaque-au-quebec-diagnostic-des-patients-qui-presentent-un-souffle-et-suivi-des-patients-atteints-dune-maladie-valvulaire-valves-natives-et-valves-prothetiques.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/indications-justifiant-le-recours-a-limagerie-pour-le-diagnostic-des-patients-presentant-une-cephalee-primaire-ou-secondaire.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/strategies-doptimisation-de-la-pertinence-des-requetes-concernant-lirm-et-la-tdm.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/indications-de-la-tomographie-par-emission-de-positrons-tep-en-oncologie-et-pour-des-maladies-cardiovasculaires-infectieuses-inflammatoires-et-neurocerebrales.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie.html?PublicationPluginController%5Bpointer%5D=1&cHash=0418f6a646c06a27030b2f16b0da215b',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie.html?PublicationPluginController%5Bpointer%5D=2&cHash=3d2d95dc219e52dd4e3ecbc89f57d949',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie.html?PublicationPluginController%5Bpointer%5D=3&cHash=09a4fbd3131be4fd26e273d8de48d506',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/traumatologie.html?PublicationPluginController%5Bpointer%5D=4&cHash=4ebe2e6009efa50c36401eddeb28d9a2',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/mise-a-jour-des-indicateurs-de-qualite-et-de-performance-en-traumatologie-clientele-adulte.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/mesures-descriptives-et-indicateurs-de-qualite-en-soutien-a-lamelioration-de-la-qualite-des-soins-et-services-offerts-par-les-centres-dexpertise-designes-pour-la-clientele-adulte-victime-de-brulures-graves-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-des-installations-de-soins-aigus-designees-en-traumatologie-tertiaire-adulte-et-secondaire-regionale-tendances-2013-2018-aux-indicateurs-de-resultats.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/sante-mentale.html?PublicationPluginController%5Bpointer%5D=1&cHash=645935699b449be878efea2575c7ddcf',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/sante-mentale.html?PublicationPluginController%5Bpointer%5D=2&cHash=2562cd6cee3d5b0d1f736b958c527f7f',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/effets-des-chiens-dassistance-et-des-animaux-de-compagnie-chez-les-personnes-presentant-un-trouble-du-spectre-de-lautisme-ou-un-trouble-de-stress-post-traumatique.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/la-gestion-du-risque-suicidaire-et-des-comportements-dautomutilation-chez-les-jeunes-heberges-en-centre-de-readaptation-pour-jeunes-en-difficulte-dadaptation.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/trajectoire-optimale-de-services-pour-les-enfants-adolescents-et-jeunes-adultes-ayant-un-trouble-de-deficit-de-lattention-avec-ou-sans-hyperactivite-tdah-ou-des-difficultes-apparentees.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/acces-equitable-aux-services-de-psychotherapie-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/lhospitalisation-a-domicile-une-alternative-pour-desengorger-les-hopitaux-et-ameliorer-la-qualite-des-soins-aux-patients.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-de-loxygenation-extracorporelle-par-membrane-ecmo-chez-ladulte-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/modes-dorganisation-des-services-de-soins-intensifs-etat-de-connaissances-et-indicateurs-de-qualite.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/jeunes-et-familles.html?PublicationPluginController%5Bpointer%5D=1&cHash=179908a26f0c8c269e2a5a03abf27cce',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/jeunes-et-familles.html?PublicationPluginController%5Bpointer%5D=2&cHash=2b3daf2800373aaba418f75176dba942',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/jeunes-et-familles.html?PublicationPluginController%5Bpointer%5D=3&cHash=58a8ef0bcbf7386401bd5d63466f1d7d',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/besoins-des-enfants-a-risque-ou-en-situation-de-negligence-et-ceux-de-leur-famille.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/grille-danalyse-des-besoins-des-familles-suivies-dans-les-services-integres-en-perinatalite-et-pour-la-petite-enfance-sippe.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/contribution-a-la-revision-des-normes-et-standards-en-protection-de-la-jeunesse-sommaire-de-la-litterature-portant-sur-les-bonnes-pratiques-cliniques-et-organisationnelles.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-des-difficultes-et-retards-lies-au-developpement-des-enfants-et-des-jeunes-0-18-ans-recevant-des-services-en-vertu-de-la-loi-sur-la-protection-de-la-jeunesse-lpj.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/algorithme-tccl-avec-risque-de-complications-graves.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/soutien-a-limplantation-des-normes-de-qualite-en-trauma.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/mise-a-jour-du-guide-de-pratique-clinique-gpc-pour-la-readaptation-de-la-clientele-adulte-ayant-subi-un-traumatisme-craniocerebral-tcc-modere-ou-grave.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/innovations-technologiques-et-dispositifs-medicaux.html?PublicationPluginController%5Bpointer%5D=1&cHash=d85e2e17e2ca1b577af1bcd7f4c63edb',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/innovations-technologiques-et-dispositifs-medicaux.html?PublicationPluginController%5Bpointer%5D=2&cHash=be221b81445d6c37bb9cadd93d9dcd1a',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/innovations-technologiques-et-dispositifs-medicaux.html?PublicationPluginController%5Bpointer%5D=3&cHash=f501e49ecd5b9434753b0131aead807a',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-des-systemes-de-pompes-a-insuline-chez-les-patients-atteints-du-diabete-de-type-1.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-du-synviscmd-et-du-synvisc-onemd-dans-le-cadre-de-la-prise-en-charge-de-larthrose-du-genou.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/teledepistage-de-la-retinopathie-diabetique-a-laide-dune-solution-dintelligence-artificielle.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-dutilisation-des-tests-moleculaires-pour-preciser-le-diagnostic-des-nodules-thyroidiens-a-cytologie-indeterminee.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-de-lhydrogel-spaceoarmd-comme-espaceur-rectal-lors-de-la-radiotherapie-de-la-prostate.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours.html?tx_solr%5Bpage%5D=2',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours.html?tx_solr%5Bpage%5D=3',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours.html?tx_solr%5Bpage%5D=4',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours.html?tx_solr%5Bpage%5D=5',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours.html?tx_solr%5Bpage%5D=6',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours.html?tx_solr%5Bpage%5D=7',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours.html?tx_solr%5Bpage%5D=8',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours.html?tx_solr%5Bpage%5D=9',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours.html?tx_solr%5Bpage%5D=10',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/pertinence-de-referer-les-variantes-hbse-et-hbee-hb-eb-thal-de-syndromes-drepanocytaires-majeurs-sdm-vers-les-centres-de-reference-du-programme-quebecois-de-depistage-neonatal.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/immunoglobulines-usage-optimal-des-preparations-dimmunoglobulines-humaines-pour-autres-indications.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/depistage-du-syndrome-dimmunodeficience-combinee-severe.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/utilisation-de-cryotherapie-aux-extremites-en-prevention-des-neuropathies-peripheriques-induites-par-les-taxanes.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/modeles-dorganisation-des-soins-et-services-pour-les-personnes-qui-presentent-des-affections-post-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/terminologies-conflictuelles-pour-les-liquides-a-consistance-modifiee-dans-la-prise-en-charge-des-patients-dysphagiques.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/evaluation-fyibryga-afibrinogenemie-ou-hypofibrinogenemie-acquise.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/algorithme-cancer-du-sein-irradiation-partielle-apres-une-chirurgie-conservatrice.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/soins-de-plaies-1.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/diagnostic-dune-infection-urinaire-et-traitement-dune-cystite-en-1ere-intention-population-adulte-ajout-dans-le-rapport-actuel-sur-population-en-perte-dautonomie.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/deficiences-physiques-intellectuelles-et-tsa.html?PublicationPluginController%5Bpointer%5D=1&cHash=accdc52619517f5800abfbca373ec779',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/deficiences-physiques-intellectuelles-et-tsa.html?PublicationPluginController%5Bpointer%5D=2&cHash=c0f7eaddc3acc8b0f1805920ff0f2f31',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/classification-des-liquides-epaissis-pour-la-prise-en-charge-de-la-dysphagie.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-des-interventions-de-readaptation-pour-les-enfants-ages-de-0-12-ans-presentant-un-trouble-du-spectre-de-lautisme.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/troubles-graves-du-comportement-meilleures-pratiques-en-prevention-en-evaluation-et-en-intervention-aupres-des-personnes-qui-presentent-une-deficience-intellectuelle-une-deficience-physique-ou-un-trouble-du-spectre-de-lautisme.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/lautonomie-des-jeunes-ages-de-6-a-21-ans-qui-presentent-une-deficience-intellectuelle.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/ordonnances-collectives/substitution-temporaire-du-salbutamol-en-aerosol-pour-inhalation.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/ordonnances-collectives/utilisation-de-lhydroxychloroquine-et-de-la-chloroquine.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/personnes-agees.html?PublicationPluginController%5Bpointer%5D=1&cHash=9d6cf4a21c933835ce00e2956c527934',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/personnes-agees.html?PublicationPluginController%5Bpointer%5D=2&cHash=d8f7763a8ed0c87781fe6165d333a6ed',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/personnes-agees.html?PublicationPluginController%5Bpointer%5D=3&cHash=296ae748c2479ac713fe0b165905677b',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/organisation-des-soins-et-services-medicaux-en-milieu-dhebergement-et-de-soins-de-longue-duree.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/conciliation-du-milieu-de-soins-et-du-milieu-de-vie-en-centre-dhebergement-et-de-soins-de-longue-duree.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-du-continuum-de-soins-et-services-aux-aines-perspectives-pour-levolution-de-la-mesure.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/qualite-du-milieu-de-vie-en-centre-dhebergement-et-de-soins-de-longue-duree-pour-les-personnes-agees-en-perte-dautonomie.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/etat-des-pratiques-regulation-des-lieux-dhabitation-collectifs-prives-pour-aines.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/retablissement-et-reprise-des-activites/les-services-sociaux-et-de-sante-mentale-a-maintenir-a-remettre-en-place-ou-a-deployer-aupres-de-la-population-generale-lors-de-la-phase-de-retablissement-de-la-pandemie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/retablissement-et-reprise-des-activites/phase-de-retablissement-a-la-pandemie-pour-les-jeunes-en-difficulte.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/retablissement-et-reprise-des-activites/phase-de-retablissement-a-la-pandemie-pour-les-personnes-agees-ou-en-perte-dautonomie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/retablissement-et-reprise-des-activites/phase-de-retablissement-a-la-pandemie-pour-les-personnes-avec-des-problemes-de-dependance-ou-en-situation-ditinerance.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/retablissement-et-reprise-des-activites/phase-de-retablissement-a-la-pandemie-pour-les-personnes-avec-des-problemes-de-sante-mentale-ou-des-troubles-mentaux.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/retablissement-et-reprise-des-activites/phase-de-retablissement-a-la-pandemie-pour-les-personnes-ayant-une-deficience-physique.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/retablissement-et-reprise-des-activites/phase-de-retablissement-a-la-pandemie-pour-les-personnes-qui-presentent-une-deficience-intellectuelle-ou-un-trouble-du-spectre-de-lautisme.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-usage-optimal.html?PublicationPluginController%5Bpointer%5D=1&cHash=6ba5eefd3dfbfd533edd10e5533a4a73',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-usage-optimal.html?PublicationPluginController%5Bpointer%5D=2&cHash=0ec4175554bb4d0b2b7c0383c78dc47e',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-usage-optimal.html?PublicationPluginController%5Bpointer%5D=3&cHash=77b373a9dc71e50814d87bc44a20aebb',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-usage-optimal.html?PublicationPluginController%5Bpointer%5D=4&cHash=42ec7176a4d4bf0d93a7ca19a3f076af',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-usage-optimal.html?PublicationPluginController%5Bpointer%5D=5&cHash=c9b5e47cd92617f9a869ab5457d02929',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-usage-optimal.html?PublicationPluginController%5Bpointer%5D=6&cHash=9613c65aa574a2df8c282818d40d951e',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-usage-optimal.html?PublicationPluginController%5Bpointer%5D=7&cHash=d16321e90fabd99e7711670ec1ad5259',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-usage-optimal.html?PublicationPluginController%5Bpointer%5D=8&cHash=bff713c902b03001e40c7b167ac73a3c',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-usage-optimal.html?PublicationPluginController%5Bpointer%5D=9&cHash=ca36344a3be068a3848578dbefbf8ce0',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-de-lexigence-dun-essai-prealable-avec-un-immunosuppresseur-dans-les-indications-de-paiement-des-medicaments-biologiques-gastroenterologie-et-dermatologie.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/penurie-dimmunoglobulines-traitements-alternatifs-aux-immunoglobulines-humaines-non-specifiques.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/intensification-posologique-des-agents-biologiques-gastroenterologie-rhumatologie-et-dermatologie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/regard-sur-la-pandemie-covid-19-au-quebec/covid-19-regard-sur-la-frequentation-dans-les-urgences-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/regard-sur-la-pandemie-covid-19-au-quebec/covid-19-regard-sur-la-frequentation-des-urgences-par-les-adolescents-pour-certaines-problematiques-de-sante-mentale-et-psychosociales.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/premiere-vague-de-la-pandemie-de-covid-19-au-quebec/premiere-vague-de-la-pandemie-de-covid-19-au-quebec-regard-sur-les-facteurs-associes-aux-hospitalisations-et-aux-deces.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/presentations-cliniques/anosmie-perte-de-gout-obstruction-nasale-mise-a-jour-completee-01-04-2020.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/presentations-cliniques/presentation-clinique-dinfarctus.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/presentations-cliniques/maladie-de-kawasaki-et-syndrome-inflammatoire-multisystemique-chez-les-enfants.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/presentations-cliniques/manifestations-cutanees.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/presentations-cliniques/manifestations-neurologiques.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/presentations-cliniques/personnes-immunosupprimees-mise-a-jour-08-04-2022.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/presentations-cliniques/rechute-et-reinfection.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/presentations-cliniques/risques-thrombotiques.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/presentations-cliniques/signes-et-symptomes.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/presentations-cliniques/symptomes-gastrointestinaux.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/investigation-procedures-diagnostiques/anomalies-et-analyses-de-laboratoire-chez-ladulte.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/investigation-procedures-diagnostiques/application-mobile-de-telesuivi-de-signes-vitaux.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/investigation-procedures-diagnostiques/detection-moleculaire-du-sars-cov-2-chez-les-individus-asymptomatiques.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/investigation-procedures-diagnostiques/indications-et-criteres-dacces-au-test-de-detection-moleculaire-du-sars-cov-2.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/investigation-procedures-diagnostiques/outils-de-prediction-de-la-mortalite.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/investigation-procedures-diagnostiques/penurie-decouvillons.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/investigation-procedures-diagnostiques/tdm-thoracique.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/investigation-procedures-diagnostiques/tests-serologiques-mise-a-jour-completee-05-08-2020.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/investigation-procedures-diagnostiques/utilisation-pertinente-des-analyses-pour-la-detection-des-virus-respiratoires-durant-la-saison-grippale-en-contexte-de-pandemie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/approches-et-interventions-de-soutien-pour-les-personnes-qui-necessitent-des-soins-psychiatriques-et-qui-ont-ou-sont-a-risque-davoir-la-covid-19.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/approches-favorisant-lobservance-des-mesures-de-precaution-et-de-protection-aupres-des-personnes-en-situation-de-vulnerabilite.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/confinement-chez-les-jeunes-consequences-moyens-pour-mitiger-son-impact-et-pistes-pour-prioriser-les-services.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/covid-19-et-effets-de-lisolement-chez-les-aines-qui-resident-dans-un-milieu-dhebergement.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/delestage-des-lits-en-milieu-psychiatrique-et-mesures-alternatives-a-lhospitalisation.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/favoriser-les-partenariats-intersectoriels-aupres-des-enfants-des-jeunes-et-leur-famille-en-contexte-pandemique.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/la-detresse-psychologique-et-la-sante-mentale-du-personnel-du-reseau-de-la-sante-et-des-services-sociaux-dans-le-contexte-de-lactuelle-pandemie.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/effets-du-contexte-de-la-pandemie-sur-la-sante-mentale-et-mesures-a-mettre-en-place-pour-contrer-ces-effets.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/evaluation-diagnostique-du-tsa-a-distance.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/filet-de-securite-social-autour-des-enfants-et-des-jeunes-a-risque-de-subir-de-mauvais-traitements-et-pratiques-de-la-protection-de-la-jeunesse.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/interventions-favorisant-lobservance-des-mesures-de-precaution-et-de-protection-aupres-des-enfants-et-des-adolescents-en-general-et-de-ceux-en-difficulte.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/les-moyens-ou-interventions-mis-en-place-pour-limiter-les-consequences-negatives-des-mesures-restrictives-sur-le-developpement-et-le-bien-etre-des-jeunes.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/mesures-permettant-aux-personnes-qui-presentent-des-difficultes-de-mobilite-de-reduire-leur-temps-dattente-en-file-devant-les-commerces-ou-les-etablissements-publics-ou-prives-offrant-des-services-essentiels.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/pratiques-en-readaptation-physique-en-contexte-disolement-preventif-a-la-chambre.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/services-de-readaptation-essentiels-pour-les-enfants-ages-de-0-a-18-ans-ayant-une-dp-une-di-ou-un-tsa.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/socialisation-a-distance-personnes-hebergees-et-proches-aidants.html',\n",
       " 'https://www.inesss.qc.ca/covid-19/services-sociaux/teleconsultation-en-medecine-generale-et-specialisee-en-centre-dhebergement-et-de-soins-de-longue-duree.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/maladie-de-lyme.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cancerologie.html?PublicationPluginController%5Bpointer%5D=1&cHash=e9bddc1a5498f5b10617d529b1b9be4c',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cancerologie.html?PublicationPluginController%5Bpointer%5D=2&cHash=8f674429a5200798f9aa8ff01c8ddec8',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cancerologie.html?PublicationPluginController%5Bpointer%5D=3&cHash=0c17d067b4559a12f901a28e1db5fed5',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cancerologie.html?PublicationPluginController%5Bpointer%5D=4&cHash=333ba1eb2ff1e3fd60e4da832efa0761',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cancerologie.html?PublicationPluginController%5Bpointer%5D=5&cHash=a8da8e1d43fddf168fb4a8f002544258',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cancerologie.html?PublicationPluginController%5Bpointer%5D=6&cHash=767671f9371dac00afb1f2467195970d',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cancerologie.html?PublicationPluginController%5Bpointer%5D=7&cHash=140e8eee7a62156f2470840f388ebd1b',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cancerologie.html?PublicationPluginController%5Bpointer%5D=8&cHash=6df601afb762e7eb1afcb54bb16c138d',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cancerologie.html?PublicationPluginController%5Bpointer%5D=9&cHash=24eff1ce40c609f63f5861480a367ba5',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-en-contexte-quebecois-des-inhibiteurs-de-la-tyrosine-kinase-du-recepteur-du-facteur-de-croissance-epidermique-egfr-pour-le-traitement-du-cancer-du-poumon.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/injections-de-vitamine-c-a-haute-dose-chez-les-patients-atteints-dun-cancer-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/radiotherapie-adjuvante-pour-le-traitement-du-cancer-du-sein-de-stade-precoce-efficacite-et-innocuite-dune-irradiation-complete-du-sein-en-5-fractions-ultra-hypofractionnement.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/portrait-des-personnes-avec-antecedent-de-cancer-infectees-par-le-sras-cov-2-durant-les-deux-premieres-vagues-de-la-pandemie.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/c-trachomatis-et-n-gonorrhoeae-et-t-vaginalis-detection-taan-multiplex.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/meilleures-pratiques-de-validation-pour-les-analyses-de-laboratoires-regroupes.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/detection-des-enterococcus-resistant-a-la-vancomycine-erv-par-taan.html',\n",
       " 'https://www.inesss.qc.ca/projets/projets-en-cours/fiche-projet/outil-daide-a-la-decision-microbiologie-culture-de-selles.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/biologie-medicale-et-genomique/biologie-medicale-et-genomique.html?PublicationPluginController%5Bpointer%5D=1&cHash=c9b2f70bea5cf4dc91fd937326635c80',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/biologie-medicale-et-genomique/biologie-medicale-et-genomique.html?PublicationPluginController%5Bpointer%5D=2&cHash=2aec9d1da5242946aeab217bc10b3ec6',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/biologie-medicale-et-genomique/biologie-medicale-et-genomique.html?PublicationPluginController%5Bpointer%5D=3&cHash=f1871735e2be5d39b307768474f59f66',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/biologie-medicale-et-genomique/biologie-medicale-et-genomique.html?PublicationPluginController%5Bpointer%5D=4&cHash=752c0e880437a5d45dd80d1fdea184ee',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/biologie-medicale-et-genomique/biologie-medicale-et-genomique.html?PublicationPluginController%5Bpointer%5D=5&cHash=150a7a287c69d55877ab49b24704ddb0',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/detection-de-la-mutation-t790m-de-lexon-20-du-gene-egfr-dans-le-cancer-du-poumon-resistant-aux-inhibiteurs-de-legfr-sur-adn-tumoral-circulant-biopsie-liquide.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/soutien-a-limplantation-des-analyses-effectuees-par-sequencage-de-nouvelle-generation-sng.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/detection-de-chlamydia-trachomatis-neisseria-gonorrhoeae-et-trichomonas-vaginalis-par-taan.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cardiologie-et-maladies-neurovasculaires.html?PublicationPluginController%5Bpointer%5D=1&cHash=b4464bf5c01f38b279f1159d3fe64988',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cardiologie-et-maladies-neurovasculaires.html?PublicationPluginController%5Bpointer%5D=2&cHash=d5135ac5a1cb148eec83b39e4ac8e065',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cardiologie-et-maladies-neurovasculaires.html?PublicationPluginController%5Bpointer%5D=3&cHash=d5c783b99ec196e9af5a7a5a186679c8',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cardiologie-et-maladies-neurovasculaires.html?PublicationPluginController%5Bpointer%5D=4&cHash=1010c6af3dc28e0683cf9562c1247200',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cardiologie-et-maladies-neurovasculaires.html?PublicationPluginController%5Bpointer%5D=5&cHash=ebb8402283125319a82ffd7a29586f95',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cardiologie-et-maladies-neurovasculaires.html?PublicationPluginController%5Bpointer%5D=6&cHash=e50ed25424f303e5108db70a5aa6e109',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/cardiologie-et-maladies-neurovasculaires.html?PublicationPluginController%5Bpointer%5D=7&cHash=9479474276c2de2cf6b6fb0c5549727c',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/profil-evolutif-de-lutilisation-et-des-resultats-cliniques-de-limplantation-valvulaire-aortique-par-catheter-tavi-et-par-voie-chirurgicale-rva-au-quebec-evaluation-en-contexte-reel-de-soins-de-2013-a-2019.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-du-depistage-neonatal-des-cardiopathies-congenitales-graves-par-saturometrie-oxymetrie-de-pouls.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/dispositifs-dassistance-ventriculaire-gauche-de-longue-duree-profil-evolutif-dutilisation-et-resultats-cliniques-en-contexte-reel-de-soins-au-quebec-de-2010-a-2017.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/normes-relatives-a-la-prise-en-charge-de-linfarctus-aigu-du-myocarde-avec-elevation-du-segment-st-iamest-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/services-externes-intensifs-pour-la-clientele-jeunesse-presentant-des-troubles-lies-a-lutilisation-de-substances-psychoactives.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/la-gestion-du-sevrage-dans-les-services-de-readaptation-en-dependance-regard-sur-les-pratiques-dici-et-dailleurs.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/modeles-de-dispensation-des-soins-et-services-aux-personnes-presentant-des-troubles-concomitants-de-sante-mentale-et-de-dependance.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/efficacite-de-lapproche-logement-dabord-pour-les-personnes-en-situation-ditinerance-vivant-avec-des-troubles-mentaux-ou-des-troubles-lies-aux-substances-psychoactives.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/depistage-et-pratiques-cliniques-preventives.html?PublicationPluginController%5Bpointer%5D=1&cHash=2a3edc0393720243ad60485c472ca688',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/depistage-et-pratiques-cliniques-preventives.html?PublicationPluginController%5Bpointer%5D=2&cHash=7b399fb3c79460f82692d2ecca63eebf',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/depistage-et-pratiques-cliniques-preventives.html?PublicationPluginController%5Bpointer%5D=3&cHash=cf90ffaa7ab58a3099ec8c1c856d3e56',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/depistage-et-pratiques-cliniques-preventives.html?PublicationPluginController%5Bpointer%5D=4&cHash=99c39daafbdd315653825a8f04354194',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/depistage-et-pratiques-cliniques-preventives.html?PublicationPluginController%5Bpointer%5D=5&cHash=de1e4071697dbd939f38aa9e4ba8a24c',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/depistage-et-pratiques-cliniques-preventives.html?PublicationPluginController%5Bpointer%5D=6&cHash=1fae96bb888f1b524df1478b32c7e8ed',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-de-la-pertinence-du-depistage-neonatal-du-deficit-immunitaire-combine-severe-scid.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-du-cancer-du-col-de-luterus-au-quebec-recommandations-pour-limplantation-du-test-de-detection-des-virus-du-papillome-humain-test-vph-comme-test-de-depistage-primaire.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-de-la-pertinence-du-depistage-neonatal-de-lamyotrophie-spinale.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/services-sociaux-generaux.html?PublicationPluginController%5Bpointer%5D=1&cHash=93d95f0c6767aa64f050c4fa1c226a0e',\n",
       " 'https://www.inesss.qc.ca/thematiques/services-sociaux/services-sociaux-generaux.html?PublicationPluginController%5Bpointer%5D=2&cHash=e65f2f247c02aff64d5be671337307ff',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/trajectoires-de-services-menant-a-levaluation-diagnostique-des-troubles-neurodeveloppementaux-chez-les-enfants-de-la-naissance-a-sept-ans.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/organisation-des-soins-et-services-en-lien-avec-les-niveaux-de-soins-alternatifs-nsa.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/mecanismes-dacces-aux-services-de-proximite.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription-1.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/webinaires-et-capsules-videos.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/toutes-les-nouveautes.html?tx_news_pi1%5B%40widget_0%5D%5BcurrentPage%5D=2&cHash=5bc488be28940d3aa155e55c2721da0c',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/toutes-les-nouveautes.html?tx_news_pi1%5B%40widget_0%5D%5BcurrentPage%5D=3&cHash=7db709273cc6b3484b754fef120f6022',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/toutes-les-nouveautes.html?tx_news_pi1%5B%40widget_0%5D%5BcurrentPage%5D=4&cHash=a3157375e76d79bc5590e8870cef8caf',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/toutes-les-nouveautes.html?tx_news_pi1%5B%40widget_0%5D%5BcurrentPage%5D=5&cHash=12b8e2586583dbd3f7fd97650e628021',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/toutes-les-nouveautes.html?tx_news_pi1%5B%40widget_0%5D%5BcurrentPage%5D=6&cHash=d6736cbd03b874fe552898c677853c72',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/toutes-les-nouveautes.html?tx_news_pi1%5B%40widget_0%5D%5BcurrentPage%5D=7&cHash=db2c0ca308f3ba76add6becaa04a1e47',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/toutes-les-nouveautes.html?tx_news_pi1%5B%40widget_0%5D%5BcurrentPage%5D=8&cHash=8fcf9a148fef10b54ced9e1f4c48ed44',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/toutes-les-nouveautes.html?tx_news_pi1%5B%40widget_0%5D%5BcurrentPage%5D=9&cHash=a9c5596662ad24655b1d54f5098061ac',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/toutes-les-nouveautes.html?tx_news_pi1%5B%40widget_0%5D%5BcurrentPage%5D=10&cHash=c9f54e848d396872f07021bd4069e517',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/toutes-les-nouveautes.html?tx_news_pi1%5B%40widget_0%5D%5BcurrentPage%5D=51&cHash=119499702dc7f78afe45e461d4d8b831',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/suivi-de-levolution-de-lepidemie-de-covid-19-portrait-et-projections-des-hospitalisations-mise-a-jour-du-22-juin-2022-1.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/suivi-de-levolution-de-lepidemie-de-covid-19-portrait-et-projections-des-hospitalisations-mise-a-jour-du-22-juin-2022.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/publication-dun-etat-des-pratiques-et-dun-etat-des-connaissances.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/nomination-de-la-dre-michele-de-guise-au-poste-de-presidente-directrice-generale-de-linstitut-national-dexcellence-en-sante-et-en-services-sociaux.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/suivi-de-levolution-de-lepidemie-de-covid-19-portrait-et-projections-des-hospitalisations-mise-a-jour-du-8-juin-2022-1.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/suivi-de-levolution-de-lepidemie-de-covid-19-portrait-et-projections-des-hospitalisations-mise-a-jour-du-8-juin-2022.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/parlons-des-soins-de-sante-en-arthrose-du-genou-au-quebec-et-du-plasma-riche-en-plaquettes.html',\n",
       " 'https://www.inesss.qc.ca/fileadmin/doc/INESSS/Transparence/mind.html',\n",
       " 'https://www.inesss.qc.ca/index.php?id=42&L=1',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/les-caracteristiques-lhistorique-et-limplantation-du-continuum-de-services-en-traumatologie-du-quebec-1991-2012.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/ocaliva-cholangite-biliaire-primitive-4267.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/monocor-404.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/brexidol-20-446.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lutathera-tumeurs-neuroendocrines-gastro-entero-pancreatiques-4659.html',\n",
       " 'https://www.inesss.qc.ca/outils-cliniques/outils-pour-professionnels-maladie-dalzheimer-et-autres-troubles-neurocognitifs.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/sprycel-640.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/creation-et-caracterisation-dune-cohorte-quebecoise-de-patients-atteints-dun-cancer-du-poumon-a-laide-de-donnees-clinico-administratives-1.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/esbriet-2397.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/esbriet-2102.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?DemandePluginController%5BAUTRESEVALUATIONS_champDeTri%5D=nom_commercial&DemandePluginController%5BAUTRESEVALUATIONS_nom_commercial_triAscDesc%5D=DESC&DemandePluginController%5Bonglet%5D=2&cHash=bb4d32703e3676e5c58198eedad3dea6',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/fora-test-ngo-3410.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/implant-de-gel-xen45-pour-la-chirurgie-micro-invasive-du-glaucome-cmig.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/systeme-de-mesure-du-glucose-en-continu-guardian-connectmc-medtronic.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/implantation-conditionnelle-des-technologies-innovantes.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/systeme-flash-de-surveillance-du-glucose-freestyle-libremc-abbott-mise-a-jour-8-avril-2020.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/valeur-therapeutique-de-loxygenotherapie-hyperbare-chez-les-enfants-avec-une-paralysie-cerebrale.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/esbriet-4581.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/enbrel-297.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/enbrel-337.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/rapamune-348.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/premplus-368.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/minocin-1278.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/minocin-1301.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/truxima-lnh-llc-gpa-pam-et-par-6306.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tykess-mesure-de-la-glycemie-6071.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/abrilada-6067.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/alecensaro-cancer-du-poumon-6292.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/emgality-5901.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/idacio-5944.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adcetris-2515.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/afinitor-2552.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/alimta-2516.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/aquacel-ag-foam-2546.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/aquacel-ag-foam-2547.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/aquacel-extra-hydrofiber-10-cm-x-10-cm-100-cm2-15-cm-x-15-cm-225-cm2-2545.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/aquacel-extra-hydrofiber-5-cm-x-5-cm-25-cm2-4691.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/axiron-2602.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/bravo-2517.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/bystolic-2553.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/carbocal-d-2000-2518.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/coaguchek-xs-pt-test-2519.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/eliquis-2551.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/erbitux-2520.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/fibristal-2521.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/fycompa-2522.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/spinraza-amyotrophie-spinale-5q-6241.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/default-d6182e9e12-44ce914c9a.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/default-d6182e9e12-22.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avonex-pen-et-avonex-ps-sclerose-plaques-5305.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tecfidera-sclerose-plaques-5300.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/spinraza-amyotrophie-spinale-5q-type-ii-type-iii-ou-presymptomatique-4799.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/spinraza-4426.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/spinraza-4428.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/spinraza-amyotrophie-spinale-5q-type-i-4769.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/zinbryta-4185.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/plegridy-3512.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tecfidera-3107.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tecfidera-2835.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avonex-ps-2842.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avonex-pen-2841.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tecfidera-2667.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tecfidera-2539.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/fampyra-2029.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/fampyra-1739.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tysabri-807.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tysabri-785.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tysabri-726.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tysabri-51.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avonex-4.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avonex-72.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avonex-77.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/amevive-166.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avonex-1248.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avonex-1247.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/copaxone-1249.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/k-citra-10-solution-3099.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/cubicin-696.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/advicor-642.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/trosec-122.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/advicor-90.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/niaspan-182.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/envarsus-5846.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/movapo-maladie-parkinson-5798.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/envarsus-pa-greffe-hepatique-4855.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/envarsus-pa-greffe-renale-5157.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/iclusig-leucemie-lymphoblastique-aiguee-4936.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/nucynta-liberation-prolongee-douleur-4651.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/movapo-parkinson-4302.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/plan-b-4370.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/iclusig-3849.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/iclusig-3850.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/plan-b-3860.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/iclusig-3503.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/plan-b-3511.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/iclusig-3414.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/veregen-2994.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/metadol-d-2824.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/oralair-3001.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/trelstar-2634.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/oralair-1995.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/abstral-1416.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/seasonique-1212.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/seasonale-723.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tridural-708.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/trelstar-et-trelstar-la-87.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/twinject-61.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/oxytrol-149.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/androderm-357.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/plan-b-405.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/oxytrol-hyperactivite-vesicale-4575.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lolo-3506.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/actonel-3404.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/constella-3255.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/actonel-dr-2803.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lolo-2822.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/strategies-de-priorisation-des-patients-en-attente-dune-coloscopie-apres-un-resultat-positif-au-test-immunochimique-de-recherche-de-sang-occulte-dans-les-selles-rsosi.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/densite-mammographique-et-depistage-du-cancer-du-sein.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lovenox-1321.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/bystolic-2300.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adcetris-5362.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adcetris-5357.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adcetris-lymphome-t-peripherique-5161.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adcetris-lymphome-hodgkin-5295.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adcetris-lymphome-hodgkin-4798.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adcetris-oncologie-5047.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adcetris-lymphome-hodgkin-3eme-intention-4938.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adcetris-lymphome-hodgkin-consolidation-4939.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adcetris-4285.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adcetris-2662.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adcetris-2296.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-usage-optimal.html?PublicationPluginController%5Bpointer%5D=10&cHash=3479fc144e11a8da2ad7c4717711de2f',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/guides-dusage-optimal-pour-les-soins-oculaires.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/portrait-de-lusage-des-opioides-chez-les-personnes-couvertes-par-le-regime-public-dassurance-medicaments-du-quebec.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-optimal-des-antipsychotiques-et-la-prise-en-charge-non-pharmacologique-des-symptomes-comportementaux-et-psychologiques-de-la-demence-chez-les-personnes-atteintes-de-troubles-neurocognitifs-majeurs-qui-resident-en-centre-dhebergement-et-de-soins-de-l.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/les-classements-des-substances-polymyxine-b-et-ses-sels-et-gramicidine-et-ses-sels-pour-un-usage-oto-ophtalmique.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/clomifene-citrate-de-pma-6113.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/kymriah-et-yescarta-lymphome-grandes-cellules-b-5843.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/trulicity-et-victoza-diabete-5665.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/fulvestrant-cancer-sein-5491.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/cysteamine-preparation-ophtalmique-5437.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/proleukin-neuroblastomes-5206.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/gelnique-1591.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/xeomin-809.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/bd-saline-sp-nacl-09-736.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/metadol-743.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/xyrem-750.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/formules-nutritives-700.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/n-a-645.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/peglyte-649.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/preparations-magistrales-ophtalmiques-204.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/inomax-129.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/venofer-112.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/metadol-88.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/phoslo-93.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/formules-nutritives-76.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/pansements-de-base-97.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/neocate-et-neocate-junior-178.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/penlac-145.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/ratio-nystatin-139.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/pansements-specialises-237.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/periostat-225.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/metadol-243.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/pansements-316.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/novorapid-323.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/neocate-one-355.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/breyanzi-lymphome-a-grandes-cellules-b-5996.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-6000.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-5938.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/onureg-leucemie-myeloide-aiguee-5837.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/reblozyl-5790.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-5711.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/default-d6182e9e12-71.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-5527.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/default-d6182e9e12-32.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/default-6283c7d417.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-cancer-rein-5341.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-melanome-4973.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/yervoy-melanome-5158.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-oncologie-4997.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/sprycel-oncologie-4998.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/yervoy-oncologie-4999.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/sprycel-leucemie-lymphoblastique-aiguee-4937.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-adjuvant-4902.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-melanome-4903.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-toutes-indications-4863.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-carcinome-hepatocellulaire-4609.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-cancer-rein-4588.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-lymphome-hodgkin-4518.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/daklinza-4513.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-cancer-poumon-4390.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-4486.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/eliquis-4368.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-melanome-4177.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-melanome-4975.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-4266.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/actikerall-keratose-actinique-4422.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/ozanex-impetigo-4433.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/actikerall-4081.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/actikerall-3872.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/epuris-2812.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-de-la-rifapentine-pour-le-traitement-de-linfection-tuberculeuse-latente.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/hemlibramc-mise-a-jour-de-la-liste-des-produits-du-systeme-du-sang-du-quebec-decembre-2019.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/trousse-de-soutien-a-limplantation-du-mayo-portland-adaptability-inventory-4-mpai-4.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/esperoctmc-mise-a-jour-de-la-liste-des-produits-du-systeme-du-sang-du-quebec-octobre-2019.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/alphanatemc-mise-a-jour-de-la-liste-des-produits-du-systeme-du-sang-du-quebec-septembre-2019.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-des-erreurs-innees-du-metabolisme.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/systemes-apprenants-et-maladies-chroniques.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/strategies-de-cessation-tabagique.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-des-accelerateurs-lineaires-avec-irm-pour-les-traitements-de-radiotherapie-en-temps-reel.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/actonel-769.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/actos-et-autres-1024.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/adderall-xr-770.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/alimta-771.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/apo-flavoxate-772.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/aranesp-773.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avandamet-1023.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avandia-768.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avastin-774.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/eprex-1025.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/flolan-1027.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/forteo-775.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/inspra-776.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/pansements-777.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/premarin-778.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/premplus-1026.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/prezista-779.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/relenza-780.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/remodulin-1028.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/soliris-781.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/stelara-782.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tamiflu-783.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tracleer-784.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/xarelto-786.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/yaz-787.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/on-call-vivid-4014.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/on-call-vivid-3696.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/relenza-influenza-5727.html?DemandePluginController%5Bonglet%5D=2&cHash=25986745f329a5020443ba1398131e4b',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tamiflu-et-versions-generiques-influenza.html?DemandePluginController%5Bonglet%5D=2&cHash=25986745f329a5020443ba1398131e4b',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/gravol-1286.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tavalisse-thrombopenie-immune-5981.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/alecensaro-cancer-poumon-4473.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/besponsa-leucemie-lymphoblastique-aigue-4695.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/fasenra-asthme-eosinophilique-grave-4472.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/foam-lite-convatec-traitement-plaies-4585.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lynparza-cancer-ovaire-4628.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/nucala-asthme-eosinophilique-grave-4694.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/ozempic-diabete-type-2-4434.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/procysbi-cystinose-nephropathique-4536.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/rekovelle-stimulation-ovarienne-4506.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/stivarga-carcinome-hepatocellulaire-4495.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/taltz-arthrite-psoriasique-4624.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/trelegy-ellipta-mpoc-4520.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/xeljanz-xr-polyarthrite-rhumatoide-4589.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/kadian-601.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/amatine-637.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/folotyn-lymphome-t-peripherique-5242.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lancora-insuffisance-cardiaque-4945.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/folotyn-lymphome-t-peripherique-4626.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/viacoram-hypertension-arterielle-essentielle-4648.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/zevalin-4825.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lancora-insuffisance-cardiaque-4174.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lixiana-fibrillation-auriculaire-4356.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lixiana-thromboembolies-veineuses-4357.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/viacoram-4091.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/viacoram-3901.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/diamicron-mr-1063.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/preterax-262.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/biprel-265.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/starnoc-328.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/diamicron-341.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/diamicron-mr-354.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/diamicron-452.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/basaglar-et-basaglar-kwikpen-4275.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/blincyto-lla-ph-adulte-4265.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/brenzys-seringue-et-stylo-4276.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/cosentyx-et-cosentyx-stylo-4269.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/cosentyx-et-cosentyx-stylo-4270.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/imbruvica-4274.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/imbruvica-4273.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/keytruda-4268.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lenvima-4272.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/orfadin-4271.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/macugen-84.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tamiflu-85.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/suivi-de-levolution-de-lepidemie-de-covid-19-risques-dhospitalisation-et-projections-des-besoins-hospitaliers-mise-a-jour-du-30-decembre-2021.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/mise-a-jour-dans-la-section-covid-19-du-site-web-de-linesss.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/suivi-de-levolution-de-lepidemie-de-covid-19-risques-dhospitalisation-et-projections-des-besoins-hospitaliers-mise-a-jour-du-22-decembre-2021.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/suivi-de-levolution-de-lepidemie-de-covid-19-risques-dhospitalisation-et-projections-des-besoins-hospitaliers-mise-a-jour-du-16-decembre-2021.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/publication-du-plan-strategique-2021-2024-de-linesss.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/suivi-de-levolution-de-lepidemie-de-covid-19-risques-dhospitalisation-et-projections-des-besoins-hospitaliers-mise-a-jour-du-9-decembre-2021.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/suivi-de-levolution-de-lepidemie-de-covid-19-risques-dhospitalisation-et-projections-des-besoins-hospitaliers-mise-a-jour-du-2-decembre-2021.html',\n",
       " 'https://www.inesss.qc.ca/accueil/nouveaute/publication-de-letat-de-connaissances-concernant-levaluation-des-interventions-de-readaptation-pour-les-enfants-ages-de-0-12-ans-presentant-un-trouble-du-spectre-de-lautisme-tsa.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/advair-diskus-et-advair-255.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avandamet-261.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/betaseron-1244.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/betaseron-1246.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/crestor-250.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/elidel-253.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/gen-clozapine-251.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/rapamune-252.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/rebif-1245.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/rebif-1242.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/spiriva-254.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/symbicort-turbuhaler-1240.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/toutes-les-marques-de-warfarine-sodique-260.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/xeloda-259.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/reevaluation-de-rebinynmc-nonacog-beta-pegol-hemophilie-de-type-b.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-et-indications-de-transmission-des-prelevements-chirurgicaux-au-laboratoire-danatomopathologie.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/zomig-481.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/merrem-1285.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/accolate-518.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/arimidex-560.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tomudex-551.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/arimidex-579.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/inadine-1350.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/agenerase-361.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/wellbutrin-sr-395.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/zyban-389.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/relenza-416.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/advair-diskus-426.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/ziagen-441.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/malarone-477.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/amerge-486.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/raxar-495.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/retrovir-1283.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/wellbutrin-sr-505.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/pylorid-520.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/pylorid-531.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/imitrex-564.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/valtrex-558.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/serevent-598.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/valtrex-589.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/serevent-635.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/abilify-848.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/aclasta-849.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/afinitor-850.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/avastin-851.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/azilect-852.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/champix-853.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/cosopt-sans-preservateur-854.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/cymbalta-855.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/extavia-856.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/firmagon-857.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/forteo-858.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/gleevec-859.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/iressa-860.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/januvia-861.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lotemax-862.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/luveris-863.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/multaq-864.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/norditropin-simplexx-865.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/premarin-866.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/prezista-867.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/silkis-868.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tamiflu-869.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/torisel-870.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tykerb-871.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-de-afstylamc-rfviii-hemophilie-de-type-a.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/genotypage-du-rhd-foetal-par-test-prenatal-non-invasif-plasma-maternel.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/systeme-de-mesure-du-glucose-en-continu-dexcom-g6mc-dexcom.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/avis-sur-laxicabtagene-ciloleucel-pour-le-traitement-des-lymphomes-a-grandes-cellules-b-recidivants-ou-refractaires.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/limplant-retinien-argus-iimc.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/avis-sur-le-tisagenlecleucel-pour-le-traitement-de-la-leucemie-lymphoblastique-aigue-recidivante-ou-refractaire.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/avis-sur-le-tisagenlecleucel-pour-le-traitement-du-lymphome-diffus-a-grandes-cellules-b-recidivant-ou-refractaire.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/endometrin-pma-6121.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/menopur-pma-6119.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/duratocin-5626.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/rekovelle-stimulation-ovarienne-5063.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/cortiment-3878.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/bravelle-3778.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/endometrin-3779.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lutrepulse-3780.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/menopur-3781.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/repronex-3782.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/systeme-lutrepulse-3783.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/decapeptyl-2614.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/systeme-lutrepulse-2555.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/decapeptyl-2335.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/divigel-2396.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/lutrepulse-2316.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/pentasa-2322.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/divigel-2100.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/decapeptyl-1984.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/menopur-1466.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/repronex-1467.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/endometrin-1181.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/firmagon-1064.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/endometrin-884.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/menopur-1138.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/repronex-1139.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/bravelle-1019.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/neupro-2532.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/nom-commercial-a-venir-projet-aligne-inesss-acmts-sante-canada-5537.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/cabometyx-cancer-rein-4419.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/janumet-diabete-type-2-4760.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/janumet-xr-diabete-type-2-4761.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/jentadueto-diabete-type-2-4759.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/kazano-diabete-type-2-4762.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/komboglyze-diabete-type-2-4756.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/perjeta-et-herceptin-emballage-combine-cancer-sein-4570.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/segluromet-diabete-type-2-4537.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/steglatro-diabete-type-2-4538.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/synjardy-diabete-type-2-4758.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/suvexx-5529.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-de-la-sedation-et-de-lanesthesie-generale-pour-les-soins-dentaires-en-pediatrie.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/elements-facilitant-la-prise-de-decision-dans-le-contexte-du-remplacement-du-generateur-dun-defibrillateur-cardiaque-implantable-et-letat-des-pratiques-en-contexte-reel-de-soins-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/traitement-chirurgical-du-cancer-de-loesophage-qualite-et-accessibilite-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-des-defibrillateurs-cardiaques-implantables-avec-sonde-sous-cutanee.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-de-la-prolotherapie-dans-le-traitement-des-affections-musculosquelettiques-chroniques.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/services-specialises-destines-aux-personnes-souffrant-de-la-maladie-dalzheimer.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/opdivo-4486.html?DemandePluginController%5Bonglet%5D=0&cHash=00ffdd9fa17d8655f8ba588589587dc1',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription.html?DemandePluginController%5Bliste%5D=286&DemandePluginController%5Bonglet%5D=1&cHash=69f8da0cb832ed4fb8f07d9747e68d8f',\n",
       " 'https://www.inesss.qc.ca/thematiques/sante/depistage-et-pratiques-cliniques-preventives.html?PublicationPluginController%5Bpointer%5D=0&cHash=15bc3b8fc2d0682e0e5f0c6e556b0f54',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/performance-diagnostique-des-techniques-de-determination-du-statut-her-2-dans-le-cancer-du-sein.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-populationnel-du-glaucome-primitif-a-angle-ouvert.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/la-spectrometrie-de-masse-en-tandem-et-le-depistage-neonatal-sanguin-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/macrobiopsie-mammaire-par-aspiration.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/mammographie-de-depistage-une-reevaluation.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/dermatop-305.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/ethyol-132.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tobi-402.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tobi-449.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/prograf-3247.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/default-27bfee8642.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/tegsedi-polyneuropathie-attrh-4867.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/denavir-7.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/levaluation-externe-de-lorganisation-et-de-la-prestation-des-soins-en-oncologie.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/la-tomographie-par-emission-de-positrons-au-quebec.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/alphagan-482.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/hp-pac-476.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/requip-478.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/rescriptor-485.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/singulair-483.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/trusopt-1271.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/viracept-479.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/viramune-480.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/xalatan-1272.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/xeloda-484.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/folotyn-lymphome-t-peripherique-5242.html?DemandePluginController%5Bonglet%5D=0&cHash=00ffdd9fa17d8655f8ba588589587dc1',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/estracomb-472.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/estracomb-592.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/vivelle-et-estraderm-25-591.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/serpasil-616.html',\n",
       " 'https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/estracomb-632.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/portrait-de-la-revascularisation-coronarienne-par-intervention-coronarienne-percutanee-et-par-pontage-aortocoronarien-au-quebec-2015-2018.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/profil-evolutif-de-lutilisation-et-des-resultats-cliniques-de-limplantation-valvulaire-aortique-par-catheter-tavi-au-quebec-evaluation-en-contexte-reel-de-soins-de-2013-a-2018.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/portrait-du-traitement-de-laccident-vasculaire-cerebral-ischemique-en-phase-hyperaigue-au-quebec-en-2013-2014.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/portrait-de-lutilisation-et-des-resultatscliniques-de-limplantation-valvulaireaortique-par-catheter-tavi-au-quebec-resultats-dune-evaluation-sur-le-terrain-alechelle-provinciale-en-2013-2015.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/lutilisation-des-dispositifs-dassistance-ventriculaire-gauche-de-longue-duree-pour-le-traitement-de-linsuffisance-cardiaque-avancee-au-quebec-de-2010-a-2012.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/etiamest-i-et-ii-faits-saillants.html',\n",
       " 'https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-des-installations-de-soins-aigus-designees-en-traumatologie-tertiaire-adulte-et-secondair.html',\n",
       " ...]"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "liste = [lien.replace('//', \"/\") for lien in csv['Address'].tolist() if not 'actualites' in lien and not 'propos' in lien and not 'joindre' in lien and not 'communiques' in lien and not 'about' in lien and not 'nouvelles' in lien and not 'pdf' in lien and not 'gaspesie' in lien]\n",
    "liste "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\"\n",
    "0 = http/s\n",
    "1 = //\n",
    "2 = domaine principal (ex. INSPQ)\n",
    "3 = 1e sous-niveau\n",
    "4 = 2e sous-niveau\n",
    "5 = 3e sous-niveau\n",
    "etc.\n",
    "\"\"\"\n",
    "\n",
    "liens = []\n",
    "for i in range (2, 9): # On prend les liens de niveau 2 à 8\n",
    "    try:\n",
    "        liens += [lien for lien in liste if len(lien.split('/')) > i]\n",
    "    except Exception as e:\n",
    "        True"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "regroupements = {}\n",
    "\n",
    "for lien in liens:\n",
    "    for i in range(3,9):\n",
    "        try:\n",
    "            tag = lien.split('/')[i-1]\n",
    "            if tag in regroupements:\n",
    "                regroupements[tag].append(lien)\n",
    "                \n",
    "            else:\n",
    "                if len(tag)>1:\n",
    "                    regroupements[tag] = []\n",
    "\n",
    "        except Exception as e:\n",
    "            True\n",
    "\n",
    "tags = list(regroupements.keys())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "tags = [tag for tag in regroupements if len(regroupements[tag]) > 40]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['www.inesss.qc.ca',\n",
       " 'outils-cliniques',\n",
       " 'publications',\n",
       " 'thematiques',\n",
       " 'medicaments',\n",
       " 'protocoles-medicaux-nationaux-et-ordonnances-associees',\n",
       " 'covid-19',\n",
       " 'sante',\n",
       " 'biologie-medicale-et-genomique',\n",
       " 'produits-du-systeme-du-sang',\n",
       " 'services-sociaux',\n",
       " 'projets',\n",
       " 'accueil',\n",
       " 'nouveaute',\n",
       " 'repertoire-des-publications',\n",
       " 'publication',\n",
       " 'projets-en-cours',\n",
       " 'fiche-projet',\n",
       " 'medicaments-evaluation-aux-fins-dinscription',\n",
       " 'rendez-vous-des-fabricants',\n",
       " 'foire-aux-questions',\n",
       " 'traumatologie',\n",
       " 'extrait-davis-au-ministre',\n",
       " 'traitements-specifiques-a-la-covid-19',\n",
       " 'presentations-cliniques',\n",
       " 'cancerologie']"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tags"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Ça nous donne 26 tags.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "['www.inesss.qc.ca',\n",
       " 'outils-cliniques',\n",
       " 'publications',\n",
       " 'thematiques',\n",
       " 'medicaments',\n",
       " 'protocoles-medicaux-nationaux-et-ordonnances-associees',\n",
       " 'covid-19',\n",
       " 'sante',\n",
       " 'biologie-medicale-et-genomique',\n",
       " 'produits-du-systeme-du-sang',\n",
       " 'services-sociaux',\n",
       " 'projets',\n",
       " 'accueil',\n",
       " 'nouveaute',\n",
       " 'repertoire-des-publications',\n",
       " 'publication',\n",
       " 'projets-en-cours',\n",
       " 'fiche-projet',\n",
       " 'medicaments-evaluation-aux-fins-dinscription',\n",
       " 'rendez-vous-des-fabricants',\n",
       " 'foire-aux-questions',\n",
       " 'traumatologie',\n",
       " 'extrait-davis-au-ministre',\n",
       " 'traitements-specifiques-a-la-covid-19',\n",
       " 'presentations-cliniques',\n",
       " 'cancerologie']"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print('Ça nous donne {} tags.'.format(len(tags)))\n",
    "tags"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os, shutil\n",
    "from pathlib import Path\n",
    "from slugify import slugify\n",
    "\n",
    "# Créer un sous-dossier où on va stocker des nouveaux fichiers CSV correspondant aux sous-corpus\n",
    "folder_path ='../03-corpus/2-sous-corpus/'\n",
    "\n",
    "#Path(folder_path).mkdir(parents=True, exist_ok=True)\n",
    "\n",
    "\n",
    "for tag in tags:\n",
    "    file_name =  acteur + \"_\" + slugify(str(tag).strip('\\n'))\n",
    "\n",
    "    # Aller chercher les documents du sous-corpus dans le CSV du corpus principal et les copier dans un nouveau CSV\n",
    "    try:\n",
    "        data = csv[csv[\"Address\"].str.match('.*[\\-\\_\\/]'+tag+'.*')]\n",
    "        data.to_csv(folder_path + file_name + \".csv\") #encoding='ISO-8859-1'\n",
    "    except Exception as e:\n",
    "        print(tag, str(e))\n",
    "                    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(folder_path + acteur + '_sous-corpus.txt', 'w') as f:\n",
    "    for file in os.listdir(folder_path):\n",
    "        f.write(file + '\\n')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Après avoir manuellement indexé"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Regroupement dans l'arborescence du site</th>\n",
       "      <th>Sous-corpus</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>inesss_biologie-medicale-et-genomique.csv</td>\n",
       "      <td>Biologie médicale et génomique</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>inesss_cancerologie.csv</td>\n",
       "      <td>Cancérologie</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>inesss_covid-19.csv</td>\n",
       "      <td>COVID-19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>inesss_medicaments.csv</td>\n",
       "      <td>Médicaments</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>inesss_medicaments-evaluation-aux-fins-dinscri...</td>\n",
       "      <td>Médicaments</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>inesss_produits-du-systeme-du-sang.csv</td>\n",
       "      <td>Produits du système du sang</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>inesss_projets-en-cours.csv</td>\n",
       "      <td>Projets</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>inesss_protocoles-medicaux-nationaux-et-ordonn...</td>\n",
       "      <td>Protocoles médicaux nationaux</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>inesss_publication.csv</td>\n",
       "      <td>Publications</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>inesss_publications.csv</td>\n",
       "      <td>Publications</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>inesss_rendez-vous-des-fabricants.csv</td>\n",
       "      <td>Médicaments</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>inesss_repertoire-des-publications.csv</td>\n",
       "      <td>Publications</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>inesss_services-sociaux.csv</td>\n",
       "      <td>Services sociaux</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>inesss_traitements-specifiques-a-la-covid-19.csv</td>\n",
       "      <td>COVID-19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>inesss_traumatologie.csv</td>\n",
       "      <td>Traumatologie</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "             Regroupement dans l'arborescence du site  \\\n",
       "0           inesss_biologie-medicale-et-genomique.csv   \n",
       "1                             inesss_cancerologie.csv   \n",
       "2                                 inesss_covid-19.csv   \n",
       "6                              inesss_medicaments.csv   \n",
       "7   inesss_medicaments-evaluation-aux-fins-dinscri...   \n",
       "11             inesss_produits-du-systeme-du-sang.csv   \n",
       "13                        inesss_projets-en-cours.csv   \n",
       "14  inesss_protocoles-medicaux-nationaux-et-ordonn...   \n",
       "15                             inesss_publication.csv   \n",
       "16                            inesss_publications.csv   \n",
       "17              inesss_rendez-vous-des-fabricants.csv   \n",
       "18             inesss_repertoire-des-publications.csv   \n",
       "20                        inesss_services-sociaux.csv   \n",
       "22   inesss_traitements-specifiques-a-la-covid-19.csv   \n",
       "23                           inesss_traumatologie.csv   \n",
       "\n",
       "                       Sous-corpus  \n",
       "0   Biologie médicale et génomique  \n",
       "1                     Cancérologie  \n",
       "2                         COVID-19  \n",
       "6                      Médicaments  \n",
       "7                      Médicaments  \n",
       "11     Produits du système du sang  \n",
       "13                         Projets  \n",
       "14   Protocoles médicaux nationaux  \n",
       "15                    Publications  \n",
       "16                    Publications  \n",
       "17                     Médicaments  \n",
       "18                    Publications  \n",
       "20                Services sociaux  \n",
       "22                        COVID-19  \n",
       "23                   Traumatologie  "
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from pandas import read_csv\n",
    "filepath = '../03-corpus/2-sous-corpus/0-semi-automatic_tags_' + acteur + '.csv'\n",
    "with open(filepath, 'r', encoding = 'utf-8') as f:\n",
    "    csv = read_csv(f, sep=';')\n",
    "    \n",
    "# csv = csv[csv['oui/non'] != 'x']\n",
    "# csv = csv[csv['oui/non'] != 'X']\n",
    "csv = csv[csv['Sous-corpus'] != 'x']\n",
    "csv = csv[csv['Sous-corpus'] != 'X']\n",
    "\n",
    "csv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Médicaments',\n",
       " 'Biologie médicale et génomique',\n",
       " 'Services sociaux',\n",
       " 'Projets',\n",
       " 'COVID-19',\n",
       " 'Cancérologie',\n",
       " 'Publications',\n",
       " 'Traumatologie',\n",
       " 'Protocoles médicaux nationaux',\n",
       " 'Produits du système du sang']"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# tags = list(set([tag for tag in csv['oui/non'].tolist()]))\n",
    "tags = list(set([tag for tag in csv['Sous-corpus'].tolist()]))\n",
    "\n",
    "tags"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "regroupements = {tag : [] for tag in tags}\n",
    "for tag in tags:\n",
    "        tuples = csv[csv['Sous-corpus'] == tag]\n",
    "        liste = [str(t).strip('\\n') for t in tuples[\"Regroupement dans l'arborescence du site\"].tolist()]\n",
    "        regroupements[tag] = liste\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Médicaments': ['inesss_medicaments.csv',\n",
       "  'inesss_medicaments-evaluation-aux-fins-dinscription.csv',\n",
       "  'inesss_rendez-vous-des-fabricants.csv'],\n",
       " 'Biologie médicale et génomique': ['inesss_biologie-medicale-et-genomique.csv'],\n",
       " 'Services sociaux': ['inesss_services-sociaux.csv'],\n",
       " 'Projets': ['inesss_projets-en-cours.csv'],\n",
       " 'COVID-19': ['inesss_covid-19.csv',\n",
       "  'inesss_traitements-specifiques-a-la-covid-19.csv'],\n",
       " 'Cancérologie': ['inesss_cancerologie.csv'],\n",
       " 'Publications': ['inesss_publication.csv',\n",
       "  'inesss_publications.csv',\n",
       "  'inesss_repertoire-des-publications.csv'],\n",
       " 'Traumatologie': ['inesss_traumatologie.csv'],\n",
       " 'Protocoles médicaux nationaux': ['inesss_protocoles-medicaux-nationaux-et-ordonnances-associees.csv'],\n",
       " 'Produits du système du sang': ['inesss_produits-du-systeme-du-sang.csv']}"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "regroupements"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Médicaments\t1099\n",
      "Biologie médicale et génomique\t11\n",
      "Services sociaux\t41\n",
      "Projets\t30\n",
      "COVID-19\t173\n",
      "Cancérologie\t25\n",
      "Publications\t566\n",
      "Traumatologie\t31\n",
      "Protocoles médicaux nationaux\t44\n",
      "Produits du système du sang\t15\n"
     ]
    }
   ],
   "source": [
    "import pandas\n",
    "from slugify import slugify\n",
    "\n",
    "# Créer de nouveaux CSV contenant les données regroupées selon le tag qui leur est associé\n",
    "path='../03-corpus/2-sous-corpus/'\n",
    "\n",
    "for tag in regroupements:\n",
    "\n",
    "    # Aller chercher les éléments correspondant au sous-corpus dans le csv principal et les copier dans un nouveau CSV \n",
    "    dfs = []\n",
    "    path='../03-corpus/2-sous-corpus/'\n",
    "    for doc in regroupements[tag]:\n",
    "        with open(path + doc, 'r', encoding='utf-8') as f:\n",
    "            csv = read_csv(f)\n",
    "            dfs.append(csv)\n",
    "\n",
    "    # Concatenate all data into one DataFrame\n",
    "    try:\n",
    "        path='../03-corpus/2-data/1-fr/' + acteur +'/'\n",
    "        file_path = path + acteur + '_'  + slugify(str(tag)) + '.csv'\n",
    "        big_frame = pandas.concat(dfs, ignore_index=True)\n",
    "        big_frame.to_csv(file_path)\n",
    "        print(tag + \"\\t\" + str(len(big_frame)))\n",
    "\n",
    "    except Exception as e:\n",
    "        print(tag, str(e))\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3.10.5 64-bit",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.5"
  },
  "orig_nbformat": 4,
  "vscode": {
   "interpreter": {
    "hash": "79bb76bbc4f9ba1f8df5efe8db67aae07079a51dc7b5004f49990e90f5993a15"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
